1. Home
  2. VIAV vs CORT Comparison

VIAV vs CORT Comparison

Compare VIAV & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$36.20

Market Cap

9.0B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

SELL

Current Price

$113.76

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VIAV
CORT
Founded
1923
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
VIAV
CORT
Price
$36.20
$113.76
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$32.66
$96.50
AVG Volume (30 Days)
3.5M
823.3K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
$1,518,300,000.00
$761,407,000.00
Revenue This Year
$37.78
$26.08
Revenue Next Year
$10.64
$26.98
P/E Ratio
N/A
$1,224.56
Revenue Growth
40.03
12.79
52 Week Low
$12.05
$28.66
52 Week High
$60.43
$126.38

Technical Indicators

Market Signals
Indicator
VIAV
CORT
Relative Strength Index (RSI) 47.38 52.88
Support Level $34.83 $108.25
Resistance Level $39.06 $124.30
Average True Range (ATR) 1.82 5.29
MACD 0.03 -0.76
Stochastic Oscillator 45.86 61.04

Price Performance

Historical Comparison
VIAV
CORT

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc is a world-wide leader in test and measurement and optical technologies. Its test and measurement, and resilient Position, Navigation and Timing (PNT) solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, it develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets. The company's segments are Network and Service Enablement (NSE); and Optical Security and Performance Products (OSP). Majority of revenue comes from NSE segment. It has presence in Americas, Asia-Pacific, and EMEA. Majority of revenue is from America.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: